Constraint Induced Movement Therapy for Walking in Individuals Post Stroke
Key facts
- Where
- Chicago, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 75 years old?
Where in United States
- AbilitylabChicago, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Shirley Ryan AbilityLab
- Trial code
- NCT03264261
- Record updated
- 3 June 2025
- Original description
To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.Read full original descriptionShow less
To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.
Inclusion: age between 21 and 75 years; history of unilateral, supratentorial, ischemic or hemorrhagic stroke; no prior stroke; demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s); able to stand and walk (>10 meters) without physical assistance.
Exclusion: significant cardiorespiratory/metabolic disease; stroke of the brainstem or cerebellar lesions; uncontrolled hypertension (systolic > 200 mm Hg, diastolic > 110 mm Hg); other neurological or orthopedic injury that impairs locomotion; scores on the Mini Mental Status examination < 24; botox injection within 6 months of starting the study.